Back to search

Article

Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B <sub>2</sub> receptor and peptidase resistance in rat

2016-12-17

Abstract excerpt

Maximakinin (MK), an amphibian peptide possessing the C-terminal sequence of bradykinin (BK), is a BK B 2 receptor (B 2 R) agonist eliciting prolonged signaling. We reinvestigated this 19-mer for species-specific pharmacologic profile, in vivo confirmation of resistance to inactivation by angiotensin converting enzyme (ACE), value as a module for the design of fusion proteins that bind to the B 2 R in mammalia...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
caa6d729-66c2-53c0-bb9b-f8789cb59ce0
DOI
10.7287/peerj.preprints.2641v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Species-specific pharmacology of maximakinin, an amphibian homologue of bradykinin: putative prodrug activity at the human B <sub>2</sub> receptor and peptidase resistance in ratDOI 10.7287/peerj.preprints.2641v1
Select a neighboring publication to make it the new centre.